Tuberculosis (TB) experts recently released new treatment recommendations for health care providers treating patients with drug susceptible TB. It has been thirteen years since new treatment guidance was released. Updated recommendations for drug resistant TB are also in the works. The United States Preventive Service Task Force just released a new recommendation encouraging providers to [...]
Last week, 25 public health tuberculosis (TB) nurses, epidemiologists and program managers from across the state came together to talk Arizona TB. This group represented 13 counties and three tribal nations, and spent the day talking about what they’ve done, what they do, and what they’re working toward. The control of tuberculosis can never go [...]
There’s Tuberculosis (TB) and then there’s Multidrug-Resistant Tuberculosis (MDR-TB). Compared to TB that is not drug resistant, MDR-TB takes a greater human and economic toll because it requires longer treatment (24 months on average) with more expensive drugs (about $150,000) and significantly increases a patient’s risk of death (about nine percent of patients die during [...]
